CA2223154A1
(en)
*
|
1995-06-02 |
1996-12-05 |
G.D. Searle & Co. |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
JPH11507670A
(ja)
*
|
1995-06-12 |
1999-07-06 |
ジー.ディー.サール アンド カンパニー |
シクロオキシゲナーゼ−2インヒビターと5−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療
|
JPH11507669A
(ja)
*
|
1995-06-12 |
1999-07-06 |
ジー.ディー.サール アンド カンパニー |
シクロオキシゲナーゼ−2インヒビターとロイコトリエンb▲下4▼受容体アンタゴニストの組合せによる炎症と炎症関連疾患の治療
|
ATE296114T1
(de)
|
1996-02-13 |
2005-06-15 |
Searle & Co |
Zubereitungen, enthaltend einen cyclooxygenase-2- inhibitor und einen leukotrien-b4-rezeptor- antagonisten
|
ES2169351T3
(es)
|
1996-02-13 |
2002-07-01 |
Searle & Co |
Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.
|
DK0880363T3
(da)
*
|
1996-02-13 |
2003-01-20 |
Searle & Co |
Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger
|
US5908858A
(en)
*
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
TR199802049T2
(xx)
|
1996-04-12 |
1999-01-18 |
G.D.Searle & Co. |
COX-2 Inhibit�rlerinin �nilac� olarak s�bstit�e edilmi� benzens�lfonamid t�revleri.
|
DE69729946T2
(de)
|
1996-10-15 |
2005-01-20 |
G.D. Searle Llc |
Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
|
US5985930A
(en)
|
1996-11-21 |
1999-11-16 |
Pasinetti; Giulio M. |
Treatment of neurodegenerative conditions with nimesulide
|
ID18983A
(id)
*
|
1996-12-04 |
1998-05-28 |
Lilly Co Eli |
Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
|
BR9807920A
(pt)
*
|
1997-04-03 |
2000-02-22 |
Searle & Co |
Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência
|
TR200000235T2
(tr)
*
|
1997-05-22 |
2000-05-22 |
G.D. Searle &Co. |
p38 kinaz inhibitörleri olarak ikame edilmiş pirazoller.
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
BR9809451A
(pt)
*
|
1997-05-22 |
2000-06-20 |
Searle & Co |
Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
|
EP1019394A1
(de)
*
|
1997-05-22 |
2000-07-19 |
G.D. Searle & Co. |
PYRAZOLDERIVATE ALS p38-KINASE-INHIBITOREN
|
CA2294057A1
(en)
|
1997-06-13 |
1998-12-17 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
US6307047B1
(en)
*
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
AUPP042397A0
(en)
*
|
1997-11-18 |
1997-12-11 |
Fujisawa Pharmaceutical Co., Ltd. |
5-arylpyrazole compounds
|
US6025353A
(en)
*
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
NZ333399A
(en)
|
1997-12-24 |
2000-05-26 |
Sankyo Co |
Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
|
US6294558B1
(en)
|
1999-05-31 |
2001-09-25 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
US6727238B2
(en)
*
|
1998-06-11 |
2004-04-27 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
WO2000018741A2
(en)
*
|
1998-09-30 |
2000-04-06 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyrazole compounds as cox-2 inhibitors
|
US6649645B1
(en)
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
JP4632544B2
(ja)
|
1998-12-25 |
2011-02-16 |
あすか製薬株式会社 |
アミノピラゾール誘導体
|
JP4627944B2
(ja)
|
1999-06-03 |
2011-02-09 |
あすか製薬株式会社 |
置換ピラゾール化合物
|
ES2200787T3
(es)
*
|
1999-12-03 |
2004-03-16 |
Pfizer Products Inc. |
Derivados de acetileno como agentes antiinflamatorios/analgesicos.
|
ATE283048T1
(de)
*
|
1999-12-08 |
2004-12-15 |
Pharmacia Corp |
Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
CA2414674A1
(en)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
|
JP2004510705A
(ja)
|
2000-07-20 |
2004-04-08 |
ラウラス エイエス |
方法
|
HUP0302475A2
(hu)
*
|
2000-09-06 |
2003-11-28 |
Ortho-Mcneil Pharmaceutical, Inc. |
Eljárás allergia kezelésére szubsztituált pirazolok alkalmazásával
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
JP2004522754A
(ja)
*
|
2001-02-02 |
2004-07-29 |
ファルマシア・コーポレーション |
月経困難症の治療および予防のための組み合わせ治療としてシクロオキシゲナーゼ‐2阻害剤および性ステロイドを使用する方法
|
US7695736B2
(en)
|
2001-04-03 |
2010-04-13 |
Pfizer Inc. |
Reconstitutable parenteral composition
|
US20030105144A1
(en)
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Stabilized oral pharmaceutical composition
|
US6673818B2
(en)
|
2001-04-20 |
2004-01-06 |
Pharmacia Corporation |
Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
|
WO2002088107A1
(en)
|
2001-04-26 |
2002-11-07 |
Eisai Co., Ltd. |
Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
|
US7076539B2
(en)
*
|
2001-07-30 |
2006-07-11 |
Hewlett-Packard Development Company, L.P. |
Network connectivity establishment at user log-in
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
CZ20022642A3
(cs)
*
|
2001-08-27 |
2003-09-17 |
Pfizer Products Inc. |
Způsob výroby dialkylpyridylboranů
|
AU2002330096B2
(en)
|
2001-09-25 |
2007-11-08 |
Pharmacia Corporation |
Process for making substituted pyrazoles
|
US7057049B2
(en)
|
2001-09-25 |
2006-06-06 |
Pharmacia Corporation |
Process for making substituted pyrazoles
|
AU2002356301A1
(en)
|
2001-12-21 |
2003-07-15 |
Cancer Research Technology Ltd. |
3,4-diarylpyrazoles and their use in the therapy of cancer
|
JP4723242B2
(ja)
|
2002-06-12 |
2011-07-13 |
ケモセントリックス インコーポレーティッド |
炎症および免疫障害治療用ccr1アンタゴニストとして使用するための1−アリール−4−置換ピペラジン誘導体
|
US7589199B2
(en)
*
|
2002-06-12 |
2009-09-15 |
Chemocentryx, Inc. |
Substituted piperazines
|
US7842693B2
(en)
*
|
2002-06-12 |
2010-11-30 |
Chemocentryx, Inc. |
Substituted piperazines
|
US20050256130A1
(en)
*
|
2002-06-12 |
2005-11-17 |
Chemocentryx, Inc. |
Substituted piperazines
|
KR100478467B1
(ko)
*
|
2002-06-24 |
2005-03-23 |
씨제이 주식회사 |
피라졸-3-온 유도체, 그 제조방법 및 약제학적 조성물
|
US7211598B2
(en)
*
|
2002-06-28 |
2007-05-01 |
Nitromed, Inc. |
Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
CA2492342C
(en)
*
|
2002-07-22 |
2011-03-22 |
Orchid Chemicals & Pharmaceuticals Ltd. |
Novel bio-active pyrimidine derivatives
|
KR20090118994A
(ko)
|
2002-12-13 |
2009-11-18 |
워너-램버트 캄파니 엘엘씨 |
하부요로증상을 치료하기 위한 알파-2-델타 리간드
|
GB0229618D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
CL2004000234A1
(es)
*
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
DE602004016964D1
(de)
*
|
2003-02-27 |
2008-11-20 |
Smithkline Beecham Corp |
Neue verbindungen
|
TW201018661A
(en)
*
|
2003-03-14 |
2010-05-16 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
DK1622630T3
(da)
*
|
2003-05-07 |
2012-12-17 |
Osteologix As |
P009368epdk1
|
ES2275218T3
(es)
|
2003-05-07 |
2007-06-01 |
Osteologix A/S |
Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
|
WO2005003319A2
(en)
*
|
2003-07-02 |
2005-01-13 |
Diversa Corporation |
Glucanases, nucleic acids encoding them and methods for making and using them
|
WO2005037797A1
(en)
*
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
WO2005044227A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Glenmark Pharmaceuticals Limited |
Topical pharmaceutical compositions
|
US20050100594A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nilendu Sen |
Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
|
EP1708718A1
(de)
|
2004-01-22 |
2006-10-11 |
Pfizer Limited |
Triazol-derivate zur hemmung der vasopressing-antagonistischen aktivität
|
US7435831B2
(en)
*
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
CA2558211C
(en)
*
|
2004-03-03 |
2013-09-03 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
MX2007002886A
(es)
*
|
2004-09-13 |
2007-05-16 |
Ono Pharmaceutical Co |
Derivado heterociclico que contiene nitrogeno y un farmaco que contiene el mismo como el ingrediente activo.
|
US9051342B2
(en)
*
|
2004-10-13 |
2015-06-09 |
Ptc Therapeutics, Inc. |
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases
|
TW200639163A
(en)
*
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
NL2000351C2
(nl)
|
2005-12-22 |
2007-09-11 |
Pfizer Prod Inc |
Estrogeen-modulatoren.
|
BRPI0621226A2
(pt)
*
|
2006-01-19 |
2012-07-10 |
Orchid Reseach Lab Ltd |
compostos heterociclos
|
US7863446B2
(en)
*
|
2006-01-19 |
2011-01-04 |
Orchid Research Laboratories Limited |
Heterocycles
|
CN101443322A
(zh)
*
|
2006-03-10 |
2009-05-27 |
小野药品工业株式会社 |
含氮杂环衍生物及含有该衍生物作为活性成分的药物
|
WO2008033466A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
UA94979C2
(uk)
|
2006-12-22 |
2011-06-25 |
Рекордати Айеленд Лимитед |
КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
|
JP2010516679A
(ja)
*
|
2007-01-19 |
2010-05-20 |
マリンクロット インコーポレイテッド |
診断用および治療用シクロオキシゲナーゼ−2結合リガンド
|
MY151089A
(en)
*
|
2007-03-26 |
2014-04-15 |
Univ Southern California Usc Stevens |
Methods and compositions for inducing apoptosis by stimulating er stress
|
JP2010533205A
(ja)
|
2007-07-12 |
2010-10-21 |
トラガラ ファーマシューティカルズ,インク. |
癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物
|
RU2572616C2
(ru)
|
2008-02-01 |
2016-01-20 |
Оркид Рисерч Лабораториз Лимитед |
Новые гетероциклы
|
EP2285380A4
(de)
*
|
2008-05-30 |
2012-03-14 |
Summa Health Systems Llc |
Verfahren zur verwendung von tgf-b-rezeptor-hemmern oder der aktivin-like-kinase (alk)-5-hemmer a-83-01 und sb-431542 zur behandlung von augenerkrankungen und wundheilungsleiden
|
JP2012524073A
(ja)
*
|
2009-04-17 |
2012-10-11 |
スムマ ヘルス システムズ エルエルシー |
眼球瘢痕化を抑制するための形質転換成長因子−β受容体阻害剤の使用
|
WO2011038261A1
(en)
*
|
2009-09-24 |
2011-03-31 |
Selexagen Therapeutics, Inc. |
Heterocyclic kinase inhibitors
|
EP2308866A1
(de)
*
|
2009-10-09 |
2011-04-13 |
Bayer CropScience AG |
Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
|
MX2012015252A
(es)
|
2010-06-30 |
2013-05-30 |
Ironwood Pharmaceuticals Inc |
Estimuladores de sgc.
|
CN107266433A
(zh)
|
2010-11-09 |
2017-10-20 |
铁木医药有限公司 |
sGC刺激剂
|
CN104066731B
(zh)
|
2011-12-27 |
2016-06-15 |
铁木医药有限公司 |
可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
|
US10500178B2
(en)
|
2015-03-13 |
2019-12-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
LTB4 inhibition to prevent and treat human lymphedema
|
WO2016210292A1
(en)
|
2015-06-25 |
2016-12-29 |
Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
|
JP7080179B2
(ja)
|
2016-03-15 |
2022-06-03 |
ザ チルドレンズ メディカル センター コーポレーション |
造血幹細胞の増大に関する方法および組成物
|
CN110963957B
(zh)
|
2018-09-28 |
2021-10-22 |
深圳恩多凯医药科技有限公司 |
N-芳香酰胺类化合物及其制备方法和用途
|
CN113004179B
(zh)
*
|
2019-12-20 |
2022-06-24 |
江苏中旗科技股份有限公司 |
一种异噁唑草酮关键中间体的制备方法
|
US20240165148A1
(en)
|
2021-03-15 |
2024-05-23 |
Saul Yedgar |
Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases
|